These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 2274814)

  • 1. [Thymus gland pathology in myasthenia gravis: cause or consequence?].
    Zaĭrat'iants OV; Vetshev PS; Khavinson VKh; Ippolitov IKh; Shakhova OV
    Sov Med; 1990; (8):18-25. PubMed ID: 2274814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [B cell population and its autoimmune activity in the thymus of patients associated with myasthenia gravis].
    Yoshitake T; Takahama T; Kanai F; Ohnishi K; Suzuki T; Kametani Y; Itoyama S; Sugawara I; Matsunaga A
    Kyobu Geka; 1993 Dec; 46(13):1083-7; discussion 1087-9. PubMed ID: 8258907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of Bcl-2 protein in the myasthenic thymus.
    Onodera J; Nakamura S; Nagano I; tobita M; Yoshioka M; Takeda A; Oouchi M; Itoyama Y
    Ann Neurol; 1996 Apr; 39(4):521-8. PubMed ID: 8619530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-6 overproduction by cultured thymic epithelial cells from patients with myasthenia gravis is potentially involved in thymic hyperplasia.
    Cohen-Kaminsky S; Devergne O; Delattre RM; Klingel-Schmitt I; Emilie D; Galanaud P; Berrih-Aknin S
    Eur Cytokine Netw; 1993; 4(2):121-32. PubMed ID: 8318672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involution of the thymus: a possible diagnostic pitfall.
    Raica M; Cîmpean AM; Encică S; Cornea R
    Rom J Morphol Embryol; 2007; 48(2):101-6. PubMed ID: 17641795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of the thymus in the physiopathology of myasthenia].
    Eymard B; Berrih-Aknin S
    Rev Neurol (Paris); 1995 Jan; 151(1):6-15. PubMed ID: 7676132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The morphological and clinico-immunological characteristics of 2 types of myasthenia].
    Zaĭrat'iants OV; Vetshev PS; Ippolitov IKh; Shkrob LO; Belokrinitskiĭ DV; Khodzhaev ZSh; Radenska-Lopovok SG
    Arkh Patol; 1991; 53(8):22-7. PubMed ID: 1953371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reflections on the "intrathymic pathogenesis" of myasthenia gravis.
    Hohlfeld R; Wekerle H
    J Neuroimmunol; 2008 Sep; 201-202():21-7. PubMed ID: 18644632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myasthenia gravis.
    Marx A; Schultz A; Wilisch A; Nenninger R; Müller-Hermelink HK
    Verh Dtsch Ges Pathol; 1996; 80():116-26. PubMed ID: 9020569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myasthenia gravis and horror autotoxicus. A review of the current literature with two case presentations.
    Davis E
    Proc Aust Assoc Neurol; 1971; 8():23-7. PubMed ID: 5153466
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical syndromes associated with thymic disorders.
    Barnes EW; Irvine WJ
    Proc R Soc Med; 1973 Feb; 66(2):151-4. PubMed ID: 4581989
    [No Abstract]   [Full Text] [Related]  

  • 12. Thymic remodeling associated with hyperplasia in myasthenia gravis.
    Le Panse R; Bismuth J; Cizeron-Clairac G; Weiss JM; Cufi P; Dartevelle P; De Rosbo NK; Berrih-Aknin S
    Autoimmunity; 2010 Aug; 43(5-6):401-12. PubMed ID: 20402580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophage subpopulations in the thymic hyperplasia of patients with myasthenia gravis.
    Zhang J; Cohen-Kaminsky S; Berrih-Aknin S
    Hum Antibodies Hybridomas; 1995; 6(4):153-60. PubMed ID: 8688498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myasthenia gravis: a personal view of pathogenesis and mechanism, part 1.
    Simpson JA
    Muscle Nerve; 1978; 1(1):45-56. PubMed ID: 377070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and biological heterogeneity of autoimmune myasthenia gravis.
    Pal J; Rozsa C; Komoly S; Illes Z
    J Neuroimmunol; 2011 Feb; 231(1-2):43-54. PubMed ID: 21093931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Thymic lymphoid hyperplasia of myasthenia gravis patients: correlation with clinical features and efficacy of thymectomy].
    Yoshitake T; Takahama T; Kanai F; Ohnishi K; Tamura K; Suzuki T; Kametani Y; Kataoka D; Nakata H; Itoyama S
    Kyobu Geka; 1995 Jun; 48(6):447-51. PubMed ID: 7602854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional expression of receptors for calcitonin gene-related peptide, calcitonin, and vasoactive intestinal peptide in the human thymus and thymomas from myasthenia gravis patients.
    Marie J; Wakkach A; Coudray A; Chastre E; Berrih-Aknin S; Gespach C
    J Immunol; 1999 Feb; 162(4):2103-12. PubMed ID: 9973484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thymus changes in anti-MuSK-positive and -negative myasthenia gravis.
    Lauriola L; Ranelletti F; Maggiano N; Guerriero M; Punzi C; Marsili F; Bartoccioni E; Evoli A
    Neurology; 2005 Feb; 64(3):536-8. PubMed ID: 15699390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autologous mixed lymphocyte reaction in patients with myasthenia gravis: correlation with disease activity.
    Greenberg SJ; Olanow CW; Dawson DV; Crane B; Roses AD
    J Immunol; 1984 Mar; 132(3):1229-36. PubMed ID: 6229579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The distribution of parenchyma, follicles, and lymphocyte subsets in thymus of patients with myasthenia gravis, with special reference to remission after thymectomy.
    Mori T; Nomori H; Ikeda K; Kobayashi H; Iwatani K; Kobayashi T
    J Thorac Cardiovasc Surg; 2007 Feb; 133(2):364-8. PubMed ID: 17258565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.